Jenny Kristina Birgit Almkvist
Directeur/Membre du Conseil chez Cereduce AB
Profil
Jenny Kristina Birgit Almkvist is currently a Director at Cereduce AB.
Previously, she worked as the Chairman & Manager-Business Development at NemerPharma AB, Director at Curictus AB from 2009 to 2012, Investment Manager at GU Ventures AB from 2006 to 2015, and Chief Technology Officer at Slutplattan BARMI 107024 AB.
Postes actifs de Jenny Kristina Birgit Almkvist
| Sociétés | Poste | Début |
|---|---|---|
Cereduce AB
 Cereduce AB Miscellaneous Commercial ServicesCommercial Services Cereduce AB develops and offers improvement of yeast strains for the fermentation industry. It provides enzyme, chemical, and feed manufacturers with tools. The company was founded by Nils Fredrik Alexander Weschke in 2010 and is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | 02/06/2011 |
Anciens postes connus de Jenny Kristina Birgit Almkvist
| Sociétés | Poste | Fin |
|---|---|---|
GU Ventures AB
 GU Ventures AB Investment ManagersFinance GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden. | Private Equity Investor | 31/08/2015 |
Curictus AB
 Curictus AB Miscellaneous Commercial ServicesCommercial Services Curictus AB is a privately owned company based in Gothenburg, Sweden. It was founded in November 2006 by SenseGraphics AB and Dr. Martin Rydmark. The company has strong collaboration with players from both the industry and the medical field. Today its prototypes are used at six different rehabilitation centers in Sweden, Sahlgrenska University Hospital, Karolinska University Hospital at Huddinge, University Hospital in Linköping, the Fyrbodal Institue and Högsbo Hospital. They leveraged on its clinical background by attending and promoting technology at all relevant rehabilitation and stroke conferences, establishing Curictus as a presence in the stroke research community. Its collaboration partners are also encouraged to submit papers and presentations at such conferences. Curictus' core technology meets the unfulfilled need for intensive and affordable home-based stroke rehabilitation. Its goal is to be the market leader in this area. Apart from stroke rehabilitation, the medical and technology competence also has a huge potential to be applied in many other fields of neuro-rehabilitation. | Directeur/Membre du Conseil | 22/05/2012 |
NemerPharma AB
 NemerPharma AB Pharmaceuticals: MajorHealth Technology NemerPharma AB produces tetrodotoxin (TTX) in an economically and environmentally sustainable way. It is focusing on a group of marine worms producing the neurotoxin tetrodotoxin (TTX) in large quantities, and its research results are now translated into a cheap and efficient method to produce natural TTX. The company was founded in December 2008 and is headquartered in Göteborg, Sweden. | Président | - |
Slutplattan BARMI 107024 AB
 Slutplattan BARMI 107024 AB Medical SpecialtiesHealth Technology Slutplattan BARMI 107024 AB develops, markets, and sells disposable testing equipment for diagnosis and treatment of periodontitis. It also develops diagnostic method of periodontitis by providing dentists and dental hygienists with an easy-to-use chair side test, detecting active disease. The firm offers in vitro diagnostic products and one-off tests for dentists, dental hygienists, and patients. The company was founded by Maude Birgitta Wikström and Stefan Renvert in 2003 and is headquartered in Gothenburg, Sweden. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
GU Ventures AB
GU Ventures AB Investment ManagersFinance GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden. | Finance |
Slutplattan BARMI 107024 AB
Slutplattan BARMI 107024 AB Medical SpecialtiesHealth Technology Slutplattan BARMI 107024 AB develops, markets, and sells disposable testing equipment for diagnosis and treatment of periodontitis. It also develops diagnostic method of periodontitis by providing dentists and dental hygienists with an easy-to-use chair side test, detecting active disease. The firm offers in vitro diagnostic products and one-off tests for dentists, dental hygienists, and patients. The company was founded by Maude Birgitta Wikström and Stefan Renvert in 2003 and is headquartered in Gothenburg, Sweden. | Health Technology |
Curictus AB
Curictus AB Miscellaneous Commercial ServicesCommercial Services Curictus AB is a privately owned company based in Gothenburg, Sweden. It was founded in November 2006 by SenseGraphics AB and Dr. Martin Rydmark. The company has strong collaboration with players from both the industry and the medical field. Today its prototypes are used at six different rehabilitation centers in Sweden, Sahlgrenska University Hospital, Karolinska University Hospital at Huddinge, University Hospital in Linköping, the Fyrbodal Institue and Högsbo Hospital. They leveraged on its clinical background by attending and promoting technology at all relevant rehabilitation and stroke conferences, establishing Curictus as a presence in the stroke research community. Its collaboration partners are also encouraged to submit papers and presentations at such conferences. Curictus' core technology meets the unfulfilled need for intensive and affordable home-based stroke rehabilitation. Its goal is to be the market leader in this area. Apart from stroke rehabilitation, the medical and technology competence also has a huge potential to be applied in many other fields of neuro-rehabilitation. | Commercial Services |
Cereduce AB
Cereduce AB Miscellaneous Commercial ServicesCommercial Services Cereduce AB develops and offers improvement of yeast strains for the fermentation industry. It provides enzyme, chemical, and feed manufacturers with tools. The company was founded by Nils Fredrik Alexander Weschke in 2010 and is headquartered in Gothenburg, Sweden. | Commercial Services |
NemerPharma AB
NemerPharma AB Pharmaceuticals: MajorHealth Technology NemerPharma AB produces tetrodotoxin (TTX) in an economically and environmentally sustainable way. It is focusing on a group of marine worms producing the neurotoxin tetrodotoxin (TTX) in large quantities, and its research results are now translated into a cheap and efficient method to produce natural TTX. The company was founded in December 2008 and is headquartered in Göteborg, Sweden. | Health Technology |
